10x Genomics, Inc. Finance Lease, Right-of-Use Asset, Amortization
10x Genomics, Inc. (TXG) reported Finance Lease, Right-of-Use Asset, Amortization of $7.62 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-13
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $2.04M, a 12.18% increase year-over-year.
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $1.95M, a 9.41% increase year-over-year.
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-06-30 was $1.84M, a 4.82% decline year-over-year.
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $1.79M, a 22.09% decline year-over-year.
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $7.62M, a 2.71% decline from fiscal 2024.
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $7.83M, a 3.43% decline from fiscal 2023.
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $8.11M, a 6.14% increase from fiscal 2022.
- 10x Genomics, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $7.64M, a 7.03% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.99M derived: sum of 2 quarters · filed 2026-02-13 | $5.83M derived: sum of 3 quarters · filed 2026-02-13 | $7.62M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.79M derived: sum of 2 quarters · filed 2025-11-07 | $5.58M 10-Q · filed 2025-11-07 | $7.40M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $3.63M 10-Q · filed 2025-08-08 | $5.44M derived: sum of 3 quarters · filed 2026-02-13 | $7.23M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $1.79M 10-Q · filed 2025-05-09 | $3.61M derived: sum of 2 quarters · filed 2026-02-13 | $5.39M derived: sum of 3 quarters · filed 2026-02-13 | $7.32M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.60M derived: sum of 2 quarters · filed 2026-02-13 | $5.53M derived: sum of 3 quarters · filed 2026-02-13 | $7.83M 10-K · filed 2026-02-13 |
| 2024-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.71M derived: sum of 2 quarters · filed 2025-11-07 | $6.01M 10-Q · filed 2025-11-07 | $8.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $4.23M 10-Q · filed 2025-08-08 | $6.22M derived: sum of 3 quarters · filed 2026-02-13 | $8.27M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $2.30M 10-Q · filed 2025-05-09 | $4.29M derived: sum of 2 quarters · filed 2026-02-13 | $6.34M derived: sum of 3 quarters · filed 2026-02-13 | $8.27M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $4.04M derived: sum of 2 quarters · filed 2026-02-13 | $5.97M derived: sum of 3 quarters · filed 2026-02-13 | $8.11M 10-K · filed 2026-02-13 |
| 2023-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $3.98M derived: sum of 2 quarters · filed 2024-10-29 | $6.12M 10-Q · filed 2024-10-29 | $8.07M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.07M 10-Q · filed 2024-08-08 | $6.02M derived: sum of 3 quarters · filed 2025-02-13 | $7.98M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $2.13M 10-Q · filed 2024-04-30 | $4.08M derived: sum of 2 quarters · filed 2025-02-13 | $6.04M derived: sum of 3 quarters · filed 2025-02-13 | $7.99M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $3.91M derived: sum of 2 quarters · filed 2025-02-13 | $5.85M derived: sum of 3 quarters · filed 2025-02-13 | $7.64M 10-K · filed 2025-02-13 |
| 2022-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $3.90M derived: sum of 2 quarters · filed 2023-11-03 | $5.69M 10-Q · filed 2023-11-03 | $7.23M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $3.73M 10-Q · filed 2023-08-04 | $5.27M derived: sum of 3 quarters · filed 2024-02-15 | $6.85M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $1.78M 10-Q · filed 2023-05-04 | $3.33M derived: sum of 2 quarters · filed 2024-02-15 | $4.91M derived: sum of 3 quarters · filed 2024-02-15 | $7.20M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $3.12M derived: sum of 2 quarters · filed 2024-02-15 | $5.42M derived: sum of 3 quarters · filed 2024-02-15 | $7.14M 10-K · filed 2024-02-15 |
| 2021-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.88M derived: sum of 2 quarters · filed 2022-11-03 | $5.59M 10-Q · filed 2022-11-03 | $7.09M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.01M 10-Q · filed 2022-08-09 | $5.51M derived: sum of 3 quarters · filed 2023-02-16 | $6.80M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $1.72M 10-Q · filed 2022-05-05 | $3.21M derived: sum of 2 quarters · filed 2023-02-16 | $4.50M derived: sum of 3 quarters · filed 2023-02-16 | $5.65M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $2.78M derived: sum of 2 quarters · filed 2023-02-16 | $3.94M derived: sum of 3 quarters · filed 2023-02-16 | $5.01M 10-K · filed 2023-02-16 |
| 2020-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.44M derived: sum of 2 quarters · filed 2021-11-05 | $3.51M 10-Q · filed 2021-11-05 | $3.51M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $2.23M 10-Q · filed 2021-08-06 | $2.23M derived: sum of 3 quarters · filed 2022-02-18 | $2.23M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $1.07M 10-Q · filed 2021-05-07 | $1.07M derived: sum of 2 quarters · filed 2022-02-18 | $1.07M derived: sum of 3 quarters · filed 2022-02-18 | $1.07M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $0.00 derived: sum of 2 quarters · filed 2022-02-18 | $0.00 derived: sum of 3 quarters · filed 2022-02-18 | $0.00 10-K · filed 2022-02-18 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |